Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Tsuboi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2006
[A case report: Bilharzial schistosomiasis in the urinary bladder presented with gross hematuria]Toshiki Tsuboi, Kazumasa Matsumoto, Akira Irie, et al.
Urology|July 5, 2005
Cancer core distribution in patients diagnosed by extended transperineal prostate biopsyTakefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, et al.
Molecular Therapy. Nucleic Acids|January 26, 2023
Long non-coding RNA lnc-CHAF1B-3 promotes renal interstitial fibrosis by regulating EMT-related genes in renal proximal tubular cellsKentaro Imai, Takuji Ishimoto, Tomohito Doke, et al.
CEN Case Reports|May 17, 2017
A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathyMasaki Okazaki, Takaaki Yaomura, Toshiki Tsuboi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 12, 2008
[Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]Masaki Kimura, Takefumi Satoh, Miyoko Okazaki, et al.
Molecular Therapy. Nucleic Acids|January 24, 2025
<i>In vivo</i> efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidneyToshiki Tsuboi, Keita Hattori, Takuji Ishimoto, et al.
Molecular Therapy. Nucleic Acids|March 14, 2025
Erratum: <i>In vivo</i> efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidneyToshiki Tsuboi, Keita Hattori, Takuji Ishimoto, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Hinyokika Kiyo. Acta Urologica Japonica|May 12, 2006
[A case report: Bilharzial schistosomiasis in the urinary bladder presented with gross hematuria]Toshiki Tsuboi, Kazumasa Matsumoto, Akira Irie, et al.
Urology|July 5, 2005
Cancer core distribution in patients diagnosed by extended transperineal prostate biopsyTakefumi Satoh, Kazumasa Matsumoto, Tetsuo Fujita, et al.
Molecular Therapy. Nucleic Acids|January 26, 2023
Long non-coding RNA lnc-CHAF1B-3 promotes renal interstitial fibrosis by regulating EMT-related genes in renal proximal tubular cellsKentaro Imai, Takuji Ishimoto, Tomohito Doke, et al.
CEN Case Reports|May 17, 2017
A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathyMasaki Okazaki, Takaaki Yaomura, Toshiki Tsuboi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 12, 2008
[Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy]Masaki Kimura, Takefumi Satoh, Miyoko Okazaki, et al.
Molecular Therapy. Nucleic Acids|January 24, 2025
<i>In vivo</i> efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidneyToshiki Tsuboi, Keita Hattori, Takuji Ishimoto, et al.
Molecular Therapy. Nucleic Acids|March 14, 2025
Erratum: <i>In vivo</i> efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidneyToshiki Tsuboi, Keita Hattori, Takuji Ishimoto, et al.
Pageof 2